In reply to minimike:
Good question.
I’m keeping my main thought to myself but I’ll drop you a PM.
I believe some of the MAB and longevity enhanced MAB cocktails intended for prophylaxis do target the current prominent spike protein genetics.
The bigger question for me is why the UK dropped Valneva when that holds the promise of a broader immunity that should be less sensitive to RBD changes and should even endure a recombinant spike swap.
I’d far rather have a 3rd dose of Valneva than any of the spike based vaccines. Don’t get me wrong, If I was offered a 3rd dose of Pfizer I would jump at it…